Hatch, Harkin Call For Withdrawal of NDI Draft Guidance
This article was originally published in The Tan Sheet
Executive Summary
Sens. Hatch and Harkin ask FDA to craft a new document to replace the current NDI notification draft guidance, recommending the agency “provide needed clarification” on what constitutes an NDI.